Literature DB >> 12208498

Resistin expression and regulation in mouse pituitary.

Barbara A Morash1, Diane Willkinson, Ehud Ur, Michael Wilkinson.   

Abstract

Resistin, a new adipocytokine, is expressed in human, rat and mouse adipose tissue. Its putative role as a mediator of insulin resistance is controversial. We hypothesized that resistin, in common with leptin, has multiple roles in non-adipose tissues. Using reverse transcription polymerase chain reaction (RT-PCR) we show that the resistin gene (Retn) is expressed in mouse brain (hypothalamus and cortex) and pituitary gland. Immunohistochemistry revealed resistin protein in the arcuate nucleus and pituitary gland. Semi-quantitative RT-PCR analysis indicated that Retn mRNA is developmentally regulated in the pituitary. Expression was lowest at birth, increased abruptly between postnatal days 14 and 25 (four-fold; P<0.001), and declined thereafter. This peak in pituitary Retn mRNA was unaffected by early weaning but was abolished by neonatal treatment with monosodium glutamate, suggesting that the basal hypothalamus regulates pituitary Retn. Although the role(s) of endogenous resistin in mouse brain and pituitary remains to be determined, it may be distinct from its controversial involvement in insulin resistance. Our data suggest that local resistin expression could have functional implications during prepubertal maturation of the hypothalamic-pituitary system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208498     DOI: 10.1016/s0014-5793(02)03108-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Resistin expression in human granulosa cells.

Authors:  Lennard P Niles; Derek K Lobb; Na Hyea Kang; Kristen J Armstrong
Journal:  Endocrine       Date:  2012-06-29       Impact factor: 3.633

2.  Hypothalamic resistin induces hepatic insulin resistance.

Authors:  Evan D Muse; Tony K T Lam; Philipp E Scherer; Luciano Rossetti
Journal:  J Clin Invest       Date:  2007-05-24       Impact factor: 14.808

3.  ERK1/2 in the brain mediates the effects of central resistin on reducing thermogenesis in brown adipose tissue.

Authors:  Samin Kosari; Donny M Camera; John A Hawley; Martin Stebbing; Emilio Badoer
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-09-10

Review 4.  Resistin: molecular history and prognosis.

Authors:  Ronadip R Banerjee; Mitchell A Lazar
Journal:  J Mol Med (Berl)       Date:  2003-03-28       Impact factor: 4.599

Review 5.  Resistin: functional roles and therapeutic considerations for cardiovascular disease.

Authors:  Md S Jamaluddin; Sarah M Weakley; Qizhi Yao; Changyi Chen
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

6.  Resistin expression in different adipose tissue depots during rat development.

Authors:  Paula Oliver; Catalina Picó; Francisca Serra; Andreu Palou
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

Review 7.  Resistin's, obesity and insulin resistance: the continuing disconnect between rodents and humans.

Authors:  X Huang; Z Yang
Journal:  J Endocrinol Invest       Date:  2015-12-12       Impact factor: 4.256

Review 8.  Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity.

Authors:  Ebtesam A Al-Suhaimi; Adeeb Shehzad
Journal:  Eur J Med Res       Date:  2013-05-01       Impact factor: 2.175

9.  Resistin deletion protects against heart failure injury by targeting DNA damage response.

Authors:  Baoyin Zhao; Rihab Bouchareb; Djamel Lebeche
Journal:  Cardiovasc Res       Date:  2022-06-29       Impact factor: 13.081

10.  Could there be a fine-tuning role for brain-derived adipokines in the regulation of bodyweight and prevention of obesity?

Authors:  Russell E Brown
Journal:  Mcgill J Med       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.